Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Timing matters: choose or avoid depending on goals, fees, and flexibility. This guide offers practical criteria to decide for retirement planning.
21,768 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A notable stake by 140 Summer Partners LP in Acuity Brands is turning heads in the investing world. This article brea...
SpaceX may steal headlines, but the real action for investors is in the earnings reports of BlackSky, Redwire, and Ro...
A pawn shop stock has surged 135% after a major fund disclosed a fresh $39 million stake. This article breaks down th...
Celebrities walk a fine line between humor and harm. When kevin hart says oprah is off-limits, it reveals how powerfu...
Investors are pouring capital into a new class of AI startups focused on world models, a movement led by tech founder...
Looking for a single artificial intelligence stock hold to ride AI-era gains for 10 years? This guide explains why Al...
A dramatic decline can hide opportunity. I bought Oracle after it sank from its peak, balancing caution with a clear ...
SoundHound AI is pursuing an enterprise voice AI niche built on data ownership and brand protection. This article bre...
Palantir’s AI-enabled analytics engine has fueled growth, but the stock faces multiple headwinds. This article lays o...
As InMode lays out its 2026 plan, investors want clarity on growth engines, margins, and execution. This article brea...
Discover how terra innovatum (nklr) 2025 shapes investor strategy. This guide breaks down growth drivers, risks, and ...